Carolina Haass-Koffler
Title
Cited by
Cited by
Year
Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seeking
JA Simms, CL Haass-Koffler, J Bito-Onon, R Li, SE Bartlett
Neuropsychopharmacology 37 (4), 906-918, 2012
832012
Opioid use and stigma: the role of gender, language and precipitating events
K Goodyear, CL Haass-Koffler, D Chavanne
Drug and alcohol dependence 185, 339-346, 2018
782018
Pharmacological approaches to reducing craving in patients with alcohol use disorders
CL Haass-Koffler, L Leggio, GA Kenna
CNS drugs 28 (4), 343-360, 2014
682014
Pharmacotherapy for alcoholic patients with alcoholic liver disease
CL Vuittonet, M Halse, L Leggio, SB Fricchione, M Brickley, ...
American journal of health-system pharmacy 71 (15), 1265-1276, 2014
502014
Role of the α1 blocker doxazosin in alcoholism: a proof‐of‐concept randomized controlled trial
GA Kenna, CL Haass‐Koffler, WH Zywiak, SM Edwards, MB Brickley, ...
Addiction biology 21 (4), 904-914, 2016
482016
Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity
CL Haass-Koffler, SE Bartlett
Frontiers in molecular neuroscience 5, 91, 2012
442012
The α5 subunit regulates the expression and function of α4*-containing neuronal nicotinic acetylcholine receptors in the ventral-tegmental area
S Chatterjee, N Santos, J Holgate, CL Haass-Koffler, FW Hopf, V Kharazia, ...
PloS one 8 (7), e68300, 2013
432013
Ondansetron Reduces Naturalistic Drinking in Nontreatment‐Seeking Alcohol‐Dependent Individuals with the LL 5′‐HTTLPR Genotype: A Laboratory Study
GA Kenna, WH Zywiak, RM Swift, JE McGeary, JS Clifford, JR Shoaff, ...
Alcoholism: Clinical and Experimental Research 38 (6), 1567-1574, 2014
372014
Leptin levels are reduced by intravenous ghrelin administration and correlated with cue-induced alcohol craving
CL Haass-Koffler, EG Aoun, RM Swift, SM De La Monte, GA Kenna, ...
Translational psychiatry 5 (9), e646-e646, 2015
332015
Noradrenergic targets for the treatment of alcohol use disorder
CL Haass-Koffler, RM Swift, L Leggio
Psychopharmacology 235 (6), 1625-1634, 2018
262018
Defining the role of corticotropin releasing factor binding protein in alcohol consumption
CL Haass-Koffler, AT Henry, G Melkus, JA Simms, M Naemmuddin, ...
Translational psychiatry 6 (11), e953-e953, 2016
252016
A relationship between the aldosterone–mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans
EG Aoun, VA Jimenez, LF Vendruscolo, NAR Walter, E Barbier, A Ferrulli, ...
Molecular psychiatry 23 (6), 1466-1473, 2018
242018
Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin
CL Haass-Koffler, K Goodyear, WH Zywiak, M Magill, SE Eltinge, ...
Drug and alcohol dependence 177, 23-28, 2017
242017
Relationship between the thyroid axis and alcohol craving
EG Aoun, MR Lee, CL Haass-Koffler, RM Swift, G Addolorato, GA Kenna, ...
Alcohol and alcoholism 50 (1), 24-29, 2015
162015
An analytical tool that quantifies cellular morphology changes from three-dimensional fluorescence images
CL Haass-Koffler, M Naeemuddin, SE Bartlett
Journal of visualized experiments: JoVE, 2012
162012
Comparing and combining topiramate and aripiprazole on alcohol-related outcomes in a human laboratory study
CL Haass-Koffler, K Goodyear, WH Zywiak, L Leggio, GA Kenna, ...
Alcohol and Alcoholism 53 (3), 268-276, 2018
142018
Serum insulin levels are reduced by intravenous ghrelin administration but do not correlate with alcohol craving in alcohol-dependent individuals
CL Haass-Koffler, DE Giovenco, MR Lee, WH Zywiak, SM de la Monte, ...
International Journal of Neuropsychopharmacology 19 (10), pyw048, 2016
142016
Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings
GA Kenna, WH Zywiak, RM Swift, JE McGeary, JS Clifford, JR Shoaff, ...
Alcohol 48 (6), 515-522, 2014
132014
A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and …
CL Haass-Koffler, K Goodyear, VM Long, HH Tran, A Loche, R Cacciaglia, ...
European Journal of Pharmaceutical Sciences 109, 78-85, 2017
122017
Effects of idazoxan on alcohol pharmacokinetics and intoxication: a preliminary human laboratory study
CL Haass‐Koffler, L Leggio, D Davidson, RM Swift
Alcoholism: Clinical and Experimental Research 39 (4), 594-602, 2015
102015
The system can't perform the operation now. Try again later.
Articles 1–20